Author Archives: Lan Huang

Drug Development in China: Lessons Learned from Years of Clinical and Small-Molecule Experience

“Today we recognize that, to successfully protect US public health, we must think, act, and engage globally. Our interests must be broader than simply those within our own borders.†—Margaret Hamburg, US Food and Drug Administration (FDA) commissioner, 2009–2015 Many major pharmaceutical companies — including Pfizer, Novartis, Eli Lilly, Sanofi, and Bayer — have research and development centers as well as clinical and commercial activities in China. Their sales revenues are increasing with the rapid growth of China’s healthcare market,…